| Name | NCK1 divergent transcript |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have revealed that NCK1‐DT (also known as NCK1‐AS1) functions as a potent oncogenic long non‐coding RNA in several solid tumors. In cervical cancer, NCK1‐DT is transcriptionally activated—via SP1 binding—and acts as a molecular sponge for miR‑6857, thereby de‐repressing CDK1/6 to promote cell proliferation, invasion, and tumor progression. Similarly, in ovarian cancer, NCK1‐DT not only competitively binds miR‑137 to elevate NCK1 mRNA expression but also stabilizes the NCK1 protein by blocking c‐Cbl‐induced degradation, contributing to increased cell proliferation, migration, and chemoresistance. In glioma, enhanced NCK1‐DT expression facilitates temozolomide resistance by modulating the miR‑137/TRIM24 axis, while elevated levels in hepatocellular carcinoma further underscore its tumor‐promoting role."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn lung malignancies such as non‐small cell lung cancer (NSCLC) and lung squamous cell carcinoma, NCK1‐DT is significantly upregulated and correlates with aggressive disease features. Its oncogenic role in these contexts involves the modulation of microRNA networks—specifically, by sponging miR‑512‑5p and miR‑361‑5p—to indirectly regulate downstream targets such as NCK1 and ADAM10, thereby driving cell proliferation, migration, invasion, and epithelial‑mesenchymal transition. These findings highlight the therapeutic potential of targeting NCK1‐DT in lung cancer."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMoreover, in esophageal squamous cell carcinoma (ESCC), NCK1‐DT promotes oncogenesis by binding to miR‑133b, which leads to the upregulation of ENPEP and thereby enhances cell proliferation, invasion, and migration. Comprehensive reviews further emphasize that aberrant NCK1‐DT expression is a common denominator across various malignancies and even in non‐cancerous conditions such as atherosclerosis, positioning it as a promising diagnostic marker and therapeutic target."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Haiyu Li, Yongqin Jia, Junning Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-017-0249-3"}], "href": "https://doi.org/10.1038/s41419-017-0249-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29416014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29416014"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Mingsheng Chen, Yingying Cheng, Zhihai Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/"}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "TRIM24"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": "."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biother Radiopharm (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/cbr.2019.3054"}], "href": "https://doi.org/10.1089/cbr.2019.3054"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31750728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31750728"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Hua Chang, Baixue Li, Xue Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2019.11.014"}], "href": "https://doi.org/10.1016/j.bbrc.2019.11.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31761329"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31761329"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Weixin Zhou, Jie Wang, Jie Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA NCK1-AS1 Aggravates Hepatocellular Carcinoma by the miR-22-3p/YARS Axis to Activate PI3K/AKT Signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gastrointestin Liver Dis (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15403/jgld-4077"}], "href": "https://doi.org/10.15403/jgld-4077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35306563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35306563"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xiping Luo, Juan Zhou, Lingli Quan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2020.153157"}], "href": "https://doi.org/10.1016/j.prp.2020.153157"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32858372"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32858372"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "L-F Zha, L-D Zhang, H-M Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202102_24843"}], "href": "https://doi.org/10.26355/eurrev_202102_24843"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33629305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33629305"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xia Zhou, Wuan Bao, Danhong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384047.2020.1842717"}], "href": "https://doi.org/10.1080/15384047.2020.1842717"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33629937"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33629937"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Bingchen Wu, Zizong Wang, Hanlin Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NCK1-AS1 promotes the proliferation, migration, invasion, and EMT of non-small cell lung cancer by regulating the miR-361-5p/ADAM10 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histol Histopathol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14670/HH-18-604"}], "href": "https://doi.org/10.14670/HH-18-604"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36912070"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36912070"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yingfan Wang, Jie Pan, Zongzong Sun "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA NCK1-AS1-mediated regulatory functions in human diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Transl Oncol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12094-022-02948-y"}], "href": "https://doi.org/10.1007/s12094-022-02948-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36131072"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36131072"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Xiang-Yuan He, Xiu-Qi Wang, Qi-Lu Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA NCK1-AS1 functions as a ceRNA to regulate cell viability and invasion in esophageal squamous cell carcinoma via microRNA-133b/ENPEP axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2022.2138416"}], "href": "https://doi.org/10.1080/15384101.2022.2138416"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36412985"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36412985"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Mohammad Taheri, Arian Askari, Kimia Behzad Moghadam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A review on the role of NCK1 Antisense RNA 1 (NCK1-AS1) in diverse disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2023.154451"}], "href": "https://doi.org/10.1016/j.prp.2023.154451"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37028107"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37028107"}]}]}]}
|
| NCBI Gene ID | 101927597 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NCK1-DT has 1 functional associations with biological entities spanning 1 categories (cell line, cell type or tissue) extracted from 1 datasets.
Click the + buttons to view associations for NCK1-DT from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CellMarker Gene-Cell Type Associations | cell types associated with NCK1-DT gene from the CellMarker Gene-Cell Type Associations dataset. | |